Glancy
Binkow & Goldberg LLP reminds investors of GrowLife,
Inc. (“GrowLife” or the “Company”) (OTC BB:PHOT) that all purchasers
of GrowLife securities between November 14, 2013 and April 9,
2014, inclusive (the “Class Period”), have until June 17, 2014, to file
a motion to be appointed as lead plaintiff in the shareholder lawsuit.
GrowLife manufactures and supplies plant growing systems, branded
equipment and expendables, primarily for cultivation of medical
marijuana, in the United States. The Complaint alleges that throughout
the Class Period defendants issued false and misleading statements or
failed to disclose that: (1) the Company had provided inaccurate and/or
inadequate information about its stock and engaged in potentially
manipulative transactions; (2) the Company lacked adequate internal and
financial controls; and (3) as a result, the Company’s financial
statements were materially false and misleading at all relevant times.
On April 10, 2014, the Securities and Exchange Commission announced that
it was temporarily suspending trading of GrowLife securities until April
29, 2014. According to a statement issued by the SEC, trading of the
Company’s securities was suspended “because of questions that have been
raised about the accuracy and adequacy of information in the marketplace
and potentially manipulative transactions in [the Company’s] common
stock.”
If you are a member of the Class described above, you may move the Court
no later than June 17, 2014, to serve as lead plaintiff; however, you
must meet certain legal requirements. To be a member of the Class, you
need not take any action at this time; you may retain counsel of your
choice or take no action and remain an absent member of the Class. If
you wish to learn more about this action or have any questions
concerning this announcement or your rights or interests with respect to
these matters, please contact Michael
Goldberg, Esquire, of Glancy Binkow & Goldberg LLP, 1925 Century
Park East, Suite 2100, Los Angeles, California 90067, Toll-Free at (888)
773-9224, or contact Gregory Linkh, Esquire, of Glancy Binkow & Goldberg
LLP at 122 E. 42nd Street, Suite 2920, New York, New York 10168, at
(212) 682-5340, by e-mail to shareholders@glancylaw.com,
or visit our website at http://www.glancylaw.com.
This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.
Copyright Business Wire 2014